Quinn Opportunity Partners LLC Iovance Biotherapeutics, Inc. Transaction History
Quinn Opportunity Partners LLC
- $1.08 Billion
- Q2 2025
A detailed history of Quinn Opportunity Partners LLC transactions in Iovance Biotherapeutics, Inc. stock. As of the latest transaction made, Quinn Opportunity Partners LLC holds 614,200 shares of IOVA stock, worth $1.3 Million. This represents 0.1% of its overall portfolio holdings.
Number of Shares
614,200Holding current value
$1.3 Million% of portfolio
0.1%Shares
1 transactions
Others Institutions Holding IOVA
# of Institutions
318Shares Held
248MCall Options Held
1.34MPut Options Held
1.61M-
Vanguard Group Inc Valley Forge, PA27.8MShares$58.6 Million0.0% of portfolio
-
Mhr Fund Management LLC New York, NY24.4MShares$51.5 Million12.15% of portfolio
-
Black Rock Inc. New York, NY21.2MShares$44.8 Million0.0% of portfolio
-
Perceptive Advisors LLC New York, NY12.7MShares$26.8 Million1.77% of portfolio
-
State Street Corp Boston, MA11MShares$23.3 Million0.0% of portfolio
About IOVANCE BIOTHERAPEUTICS, INC.
- Ticker IOVA
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 157,800,992
- Market Cap $333M
- Description
- Iovance Biotherapeutics, Inc., a clinical-stage biotechnology company, focuses on developing and commercializing cancer immunotherapy products to harness the power of a patient's immune system to eradicate cancer cells. It has six ongoing phase 2 clinical studies, including C-144-01, of its lead product candidate, lifileucel, for the treatment o...